NHC NATIONAL HEALTHCARE CORPcompanySEC Filings & Insider Trading Activity 2026
Latest NATIONAL HEALTHCARE CORP (NHC) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on February 26, 2026, a 10-Q quarterly report filed on May 7, 2026, an 8-K current report filed on July 1, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for NATIONAL HEALTHCARE CORP (NHC) (SEC CIK 1047335), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business: Operation of skilled nursing, assisted and independent living, homecare, hospice, and behavioral health facilities across 9 states, primarily Southeastern and Midwestern U.S.
- • New expansion: Acquisition of White Oak Management with 15 skilled nursing facilities, 2 assisted living, 4 independent living, and a long-term care pharmacy adding 1,928 skilled beds in SC and NC (Aug 2024)
- • Strategic emphasis: Growth in post-acute and senior health care operations, hospice agency launches in multiple locations during 2023-2024, plus continued focus on quality via Medicare’s Five-Star system (62.5% 4-5 star rating vs 38.6% industry)
- • Quantitative metric: Skilled nursing facility occupancy up to 89.7% in 2025 from 88.6% in 2024; homecare served average census 3,834 patients with 339,344 visits in 2025
- • Noteworthy fact: FY2026 Medicare Skilled Nursing Facility payments rose 3.2% vs PY; however, FY2026 home health agency payments projected to decline 1.3%
Risk Factors
- • Regulatory risk: Medicare reimbursement cuts mandated by the Budget Control Act of 2011 impose up to 2% annual reductions extended through 2030
- • Geopolitical/macro threat: CMS Staffing Rule implementation delayed by One Big Beautiful Bill Act until October 1, 2034, creating uncertainty in labor cost planning
- • Operational/supply chain risk: Dispute with lessor National Health Investors, Inc. over Master Lease non-compliance risks losing lease on multiple facilities
- • Competitive market risk: Not-for-profit and governmental competitors benefit from tax-exempt financing and donations, intensifying competition for patients and referrals
- • Financial risk: Increasing self-insurance exposure to professional liability and workers’ compensation claims with potential for liabilities exceeding reserves
Management Discussion & Analysis
- • Revenue $1.52B in 2025, up 16.1% YoY from $1.31B in 2024; net patient revenues $1.47B, up 17.4% ($217.9M)
- • Operating margin 8.4% in 2025 vs 6.9% in 2024; net income margin 8.0% in 2025 vs 7.8% in 2024
- • Best performing: Inpatient Services with $1.32B revenue, $127.8M operating income in 2025; Worst: "All Other" category operating loss of $(29.5)M
- • Cash flow from operations $185.1M in 2025 vs $107.3M in 2024; capital expenditures $33.9M; financing cash used $136.0M (likely for debt repayment/buybacks)
- • Management highlights skilled nursing census growth, White Oak acquisition accretive, labor cost management; risks include ongoing healthcare labor shortages and inflationary pressures
Go deeper on NATIONAL HEALTHCARE CORP
Ask AI about NHC filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting NHC positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on NHC.
Annual Reports Archive10-K
AI-powered analysis of NATIONAL HEALTHCARE CORP (NHC) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of NATIONAL HEALTHCARE CORP (NHC) 10-Q quarterly reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of NATIONAL HEALTHCARE CORP (NHC) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| Profitability | |||
| Revenue | $1.1B | $1.3B | $1.5B |
| Operating Income | - | $85.8M | $128.4M |
| Net Income | $66.8M | $101.9M | $120.0M |
| Op. Margin | - | 6.6% | 8.5% |
| Net Margin | 5.9% | 7.8% | 7.9% |
| Balance Sheet | |||
| Total Assets | - | $1.5B | $1.5B |
| Equity | $908.8M | $980.2M | $1.1B |
| ROE | 7.4% | 10.4% | 11.2% |
| Per Share | |||
| EPS | $4.34 | $6.53 | $7.67 |
| Cash Flow | |||
| Operating CF | - | $107.3M | $185.1M |
| CapEx | - | $27.6M | $36.4M |
Source: XBRL financial data from NATIONAL HEALTHCARE CORP (NHC) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Jul 1, 2026 | - | - | - |
8-K | May 27, 2026 | - | - | |
8-K | May 15, 2026 | - | - | |
8-K | May 13, 2026 | - | - | |
8-K | May 8, 2026 | - | - | |
8-K | May 7, 2026 | - | - | |
10-Q | May 7, 2026 | Mar 31, 2026 | - | |
8-K | Apr 22, 2026 | - | - | - |
8-K | Feb 27, 2026 | - | Analysis | - |
10-K | Feb 26, 2026 | Dec 31, 2025 | Analysis | |
8-K | Feb 17, 2026 | - | - | |
8-K | Feb 13, 2026 | - | - | |
10-Q | Nov 6, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Aug 7, 2025 | Jun 30, 2025 | - | |
10-Q | May 8, 2025 | Mar 31, 2025 | - | |
10-K | Feb 28, 2025 | Dec 31, 2024 | - | |
SC 13G | Nov 8, 2024 | - | - | |
10-Q | Nov 7, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 8, 2024 | Jun 30, 2024 | - | |
10-Q | May 9, 2024 | Mar 31, 2024 | - | |
10-K | Feb 16, 2024 | Dec 31, 2023 | - | |
10-Q | Nov 2, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 3, 2023 | Jun 30, 2023 | - | |
10-Q | May 4, 2023 | Mar 31, 2023 | - | |
10-K | Feb 17, 2023 | Dec 31, 2022 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate NHC share value held by 13F filers tracked by SignalX, by quarter.
- Two Sigma Investments+63.5K (+329%)
- Citadel Advisors LLC+14.6K (+248%)
- Goldman Sachs Group+12.6K (+15%)
- Bank of America Corp+10.9K (+66%)
- State Street Corp+6.5K (+1%)
- Renaissance Technologies LLC14.6K (-4%)
- Dimensional Fund Advisors11.3K (-1%)
- Wells Fargo & Co9.4K (-66%)
- BlackRock6.8K (-0%)
- Citigroup3.1K (-58%)
- Franklin Resources+6.7K
- Allstate+3.8K
- Vanguard Group Inc−1.41M
- Invesco Ltd−64.0K
- JPMorgan Chase & Co−31.3K
- Coatue Management−2.2K
Source: 13F-HR filings on SEC EDGAR (aggregated from 182 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest NHC SEC filings in 2026?
NATIONAL HEALTHCARE CORP (NHC) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on May 7, 2026, an 8-K current report on July 1, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did NHC file its most recent 10-K annual report?
NATIONAL HEALTHCARE CORP (NHC) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view NHC 10-Q quarterly reports?
NATIONAL HEALTHCARE CORP (NHC)'s most recent 10-Q quarterly report was filed on May 7, 2026. SignalX displays every NHC 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has NHC filed recently?
NATIONAL HEALTHCARE CORP (NHC)'s most recent 8-K was filed on July 1, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find NHC insider trading activity (Form 4)?
SignalX aggregates every NHC Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does NHC file with the SEC?
NATIONAL HEALTHCARE CORP (NHC) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new NHC filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for NATIONAL HEALTHCARE CORP (NHC).
What is NHC's SEC CIK number?
NATIONAL HEALTHCARE CORP (NHC)'s SEC CIK (Central Index Key) number is 1047335. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1047335 to look up all NHC filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find NHC return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from NATIONAL HEALTHCARE CORP (NHC) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of NATIONAL HEALTHCARE CORP SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 76+ filings.